Navigation Links
U.S. Joins Case Against Cincinnati Health Care Facilities Alleging Kickbacks for Cardiac Services
Date:4/1/2008

WASHINGTON, April 1, 2008 /PRNewswire-USNewswire/ -- The United States has intervened in a whistleblower suit accusing The Christ Hospital, The Health Alliance of Greater Cincinnati and The Ohio Heart Health Center of defrauding federal health care programs, the Justice Department announced today. The lawsuit alleges that Christ Hospital, a full service Cincinnati-based hospital and formerly a member of The Health Alliance, and Ohio Heart, the largest cardiology group in that region of Ohio, devised a scheme that provided cardiologists improper financial incentives in exchange for generating revenue for the hospital.

The focus of the lawsuit is an outpatient cardiology testing unit within Christ Hospital known as the Heart Station, where patients receive non-invasive heart procedures such as electrocardiograms, echocardiograms and stress tests. The lawsuit alleges that, between at least 1999 and 2004, cardiologists were allocated time at the Heart Station based solely on the amount of coronary arterial bypass graph procedures and catheter lab revenues generated by each cardiologist or cardiology group for Christ Hospital during the previous year.

Many of these procedures were billed to and paid for by various federal healthcare benefit programs, including Medicare and Medicaid. Federal law makes it unlawful to provide or receive financial incentives in exchange for patient referrals. In this case, cardiologists, including those employed by Ohio Heart, were rewarded for referring business or generating revenue for Christ Hospital with the opportunity to bill for the patients they treated at the Heart Station and for any follow-up procedures that these patients required. This system for scheduling time at the Heart Station gave area cardiologists an incentive to perform certain cardiac procedures at Christ Hospital and prevented otherwise qualified cardiologists, who failed to generate income for Christ Hospital during the previous year, from
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Morgan Fairchild Joins Neurologists, Emergency Physicians and the American Stroke Association to Educate the Public About Stroke Symptoms
2. SCI Real Estate Investments Joins City of Hope to Fight Cancer
3. MLM Expert and Start-Up Specialist Jim Clayton Joins Healthy Coffee USA
4. UHW Joins Blue Ribbon Panel on the Future of St. Lukes Hospital
5. Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USAs Founders Club
6. SURGEX(TM) Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard
7. Dr. Ravi Nanda Joins OrthoSynetics(TM) as Strategic Consultant
8. First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide
9. Caring.com Joins Entrepreneurs Foundation as 200th Member
10. Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM
11. Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...Renowned oncology researcher Dr. Daniel Von Hoff, ...Advisory Board, provides an in-depth look at "... trial design that creates rapid accrual rates, su...ings, enthusiasm from investigators and patients, ...nterview is available for download from Medelis, a...
(Date:7/9/2008)...9 /PRNewswire/ -- Tricom Document Management,(Tric...gement of legacy and,current documents for a globa...fic Data Centers, Inc. (PDC), a data processing bu...ents so that they can better focus on their,core c...he latest technological advances and,state-of-the-...
(Date:7/9/2008)...f uKarma,s vertical integration strategy and will,...lth and wellness brands, LOS ANGELES, July 9 /PRN...etin Board: UKMA), a lifestyle multimedia and cons...and personal development, announced today the,firs...a in October, 2008., Xflowsion, with its revoluti...
(Date:7/9/2008)...Contributing Editor, Judy Bachrach Launches Newly,... Terminally Ill and Those ...wire/ -- (ZealousPR) -- Today, http://www.thechec...n for,the terminally ill and those who are close t...new easily accessible FORUM for readers to discuss...
Breaking Medicine News(10 mins):Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 3Health News:Tricom Document Management Expands Onshore Services with Acquisition of Pacific Data Centers, Inc. 2Health News:uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel 2Health News:Online Advice Column Receives Critical Acclaim; Baby Boomers Found Resourceful During Crisis 2
...experts have revealed that female foeticide is inc... mobile population of India. // The educated peopl...th, and poverty is not the only reason for these s...f selective abortions being made illegal in the co...
...hers belonging to the Yale School of Medicine have...regnant women are concerned can be diagnosed throu...ion in amniotic fluid. The chances of a premature ...ed through this process, according to the research...
... we know about the connection between age factor a...have found new proof that might establish this con...ng a study of baboons, it was discovered that as t...ncreased presence of old cells. It is well known t...
... from Pennsylvania school of medicine have found t...of severe stenosis or narrowed arteries in head ar.../ The result of the study conducted by Professor S...lished in the Journal Circulation. This new diag...
Other Medicine News:Health News:Link between Old Cells and Ageing probed 2
(Date:7/9/2008)... Research Has Set National Safety Standards, ...swire-USNewswire/ -- In a congressional,hearing Se...discussed the,safety and importance of the researc...Affairs (VA) as well as an absolute commitment to ...single veteran would feel improperly,treated or mi...
(Date:7/9/2008)... SAN DIEGO, July 9 /- ... announced positive results from a multiple-ascend...uate the compound,s safety,pharmacokinetics and p...overed oral drug candidate intended for the treatm...tions., The Phase 1b trial was a randomized, doub...
(Date:7/8/2008)... MAIDENHEAD, England, July 8 /PRNewswire-Firs...ldren Against the Leading,Vaccine-Preventable Caus...countries of Cyprus, Hungary, the Kingdom of,Bahra...n for announcing,their decisions to routinely immu...al disease by adding PREVENAR(TM) PCV7 (Pneumococc...
(Date:7/8/2008)... GLP-1 Has Potential to Treat Type 2 Diabetes U... Technology, CEDAR KNOLLS, N.J., July 8 /PR.... (Nasdaq: EMIS ) today announced findings from a...-1 peptide safely and effectively.,The study used ...Eligen(R),technology, and was conducted at Univers...
Breaking Medicine Technology:Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 2Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 3Benchmarking Study Report on Sales Performance Management 21730 1Benchmarking Study Report on Sales Performance Management 21730 2Consumers Urged to Avoid Raw Milk and Raw Milk Products 21727 1Derma Sciences CEO ED Quilty Discusses Company on BNN 21725 1Derma Sciences CEO ED Quilty Discusses Company on BNN 21725 2Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 1Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 2Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 3
...tudy evaluating a clinically relevant model of,nor...gent capable,of abrogating the cytotoxic effect of...d OPTISOME(tm) agent was generally well,tolerated ...ent,profile similar to conventional vincristine , ...EWSWIRE) --,Hana Biosciences (Nasdaq:HNAB), a biop...
..., NJ – June 4, 2007 – Genta,Incorporat...sults,from a Phase 2 clinical trial of its markete..., plus rituximab (Rituxan®;,Genentech/IDEC) an...ctory non-Hodgkin’s lymphoma (NHL). The data...can Society of Clinical,Oncology (ASCO) in Chicago...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
The Snellen chart remains to most popular chart design among clinicians. A range of different optotypes can be displayed in snellen format including British, sheridan-gardner, landolt Cs, tumbling Es
The PacScan 300AP is a portable, combination A-scan and pachymeter which provides easy-to-use touch screen operation. The combination of a high frequency, low noise probes and fast precise algorithms
Lightweight portable pachymeter, with compact LCD screen and optional printer. The Micropach 200P+ is extremely portable, weighing slightly more than 2 lbs (1 kg). The digital pachymeter provides a
16 segment Horizontal Prism bar provides 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45 PD. 4446 xx Horizontal Prism Bar.
Medicine Products: